YIFAN PHARMACEUTICAL CO (SZSE:002019) Days Sales Outstanding : 82.40 (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is YIFAN PHARMACEUTICAL CO Days Sales Outstanding?

YIFAN PHARMACEUTICAL CO's average Accounts Receivable for the three months ended in Mar. 2024 was ¥1,197 Mil. YIFAN PHARMACEUTICAL CO's Revenue for the three months ended in Mar. 2024 was ¥1,326 Mil. Hence, YIFAN PHARMACEUTICAL CO's Days Sales Outstanding for the three months ended in Mar. 2024 was 82.40.

The historical rank and industry rank for YIFAN PHARMACEUTICAL CO's Days Sales Outstanding or its related term are showing as below:

SZSE:002019' s Days Sales Outstanding Range Over the Past 10 Years
Min: 57.53 Med: 66.28 Max: 107.44
Current: 91.17

During the past 13 years, YIFAN PHARMACEUTICAL CO's highest Days Sales Outstanding was 107.44. The lowest was 57.53. And the median was 66.28.

SZSE:002019's Days Sales Outstanding is ranked worse than
67.73% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 72.57 vs SZSE:002019: 91.17

YIFAN PHARMACEUTICAL CO's Days Sales Outstanding declined from Mar. 2023 (109.80) to Mar. 2024 (82.40).

YIFAN PHARMACEUTICAL CO Days Sales Outstanding Historical Data

The historical data trend for YIFAN PHARMACEUTICAL CO's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YIFAN PHARMACEUTICAL CO Days Sales Outstanding Chart

YIFAN PHARMACEUTICAL CO Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

64.69

65.92

86.20

107.44

102.82

YIFAN PHARMACEUTICAL CO Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															109.80	97.31	96.81	85.65	82.40

Competitive Comparison of YIFAN PHARMACEUTICAL CO's Days Sales Outstanding

For the Drug Manufacturers - General subindustry, YIFAN PHARMACEUTICAL CO's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

YIFAN PHARMACEUTICAL CO's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, YIFAN PHARMACEUTICAL CO's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where YIFAN PHARMACEUTICAL CO's Days Sales Outstanding falls into.

YIFAN PHARMACEUTICAL CO Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

YIFAN PHARMACEUTICAL CO's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1181.36	+	1110.666)	/	2 )	/	4068.107	*	365
=	1146.013					/	4068.107	*	365
=	102.82

YIFAN PHARMACEUTICAL CO's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (1110.666	+	1284.194)	/	2 )	/	1325.969	*	365 / 4
=	1197.43					/	1325.969	*	365 / 4
=	82.40

YIFAN PHARMACEUTICAL CO (SZSE:002019) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

YIFAN PHARMACEUTICAL CO Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of YIFAN PHARMACEUTICAL CO's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

YIFAN PHARMACEUTICAL CO (SZSE:002019) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » YIFAN PHARMACEUTICAL CO LTD (SZSE:002019) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300

Website

https://en.yifanyy.com

YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.

YIFAN PHARMACEUTICAL CO (SZSE:002019) Headlines

No Headlines